Speciality Medicines Board Meeting Scheduled for 12th Nov'26 to Approve Financial Results
Speciality Medicines Ltd 路 Intimation 路 12 Nov 2026, 5:30 am
Speciality Medicines Board Meeting Scheduled for 12th Nov'26 to Approve Financial Results Speciality Medicines Limited has scheduled a Board of Directors meeting on 12th Nov'26 at its Mumbai corporate office to consider and approve the unaudited standalone financial results for the half year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities has been closed for designated insiders from 1st Oct'26 and will reopen 48 hours post the conclusion of the board meeting.
Original exchange filing (PDF)
More announcements from Speciality Medicines Ltd
- We hereby submit the Standalone Unaudited Financial Result for the half year ended on September 30, 2026 路 12 Nov 2026
- We hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on November 12, 2026, at the Corporate Office of the Company which was commenced .... 路 12 Nov 2026
- We hereby submit Voting Results and Consolidated Scrutinizer report of the 5th AGM of the Company. 路 28 Sept 2026
- We hereby submit Proceedings of 5th AGM of the Company. 路 28 Sept 2026
- We hereby Submit Annual Report of FY 2025-26. 路 04 Sept 2026
- We hereby submit Notice of 5th AGM to be held on September 28, 2026. 路 04 Sept 2026
- We hereby submit Outcome of the board meeting held on September 03, 2026 路 03 Sept 2026
- We hereby submit intimation regarding approval for Two new products in Ethiopia. 路 12 Aug 2026
